JP2013014622A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013014622A5 JP2013014622A5 JP2012230565A JP2012230565A JP2013014622A5 JP 2013014622 A5 JP2013014622 A5 JP 2013014622A5 JP 2012230565 A JP2012230565 A JP 2012230565A JP 2012230565 A JP2012230565 A JP 2012230565A JP 2013014622 A5 JP2013014622 A5 JP 2013014622A5
- Authority
- JP
- Japan
- Prior art keywords
- solvate
- pharmaceutically acceptable
- acceptable salt
- compound
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 239000012453 solvate Substances 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91817107P | 2007-03-15 | 2007-03-15 | |
| US60/918,171 | 2007-03-15 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009553612A Division JP5147866B2 (ja) | 2007-03-15 | 2008-03-12 | グルカン合成酵素阻害剤として有用であるピリダジノン誘導体 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013259117A Division JP2014051529A (ja) | 2007-03-15 | 2013-12-16 | グルカン合成酵素阻害剤として有用であるピリダジノン誘導体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013014622A JP2013014622A (ja) | 2013-01-24 |
| JP2013014622A5 true JP2013014622A5 (enExample) | 2014-02-06 |
Family
ID=39525788
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009553612A Expired - Fee Related JP5147866B2 (ja) | 2007-03-15 | 2008-03-12 | グルカン合成酵素阻害剤として有用であるピリダジノン誘導体 |
| JP2012230565A Pending JP2013014622A (ja) | 2007-03-15 | 2012-10-18 | グルカン合成酵素阻害剤として有用であるピリダジノン誘導体 |
| JP2013259117A Pending JP2014051529A (ja) | 2007-03-15 | 2013-12-16 | グルカン合成酵素阻害剤として有用であるピリダジノン誘導体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009553612A Expired - Fee Related JP5147866B2 (ja) | 2007-03-15 | 2008-03-12 | グルカン合成酵素阻害剤として有用であるピリダジノン誘導体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013259117A Pending JP2014051529A (ja) | 2007-03-15 | 2013-12-16 | グルカン合成酵素阻害剤として有用であるピリダジノン誘導体 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8232274B2 (enExample) |
| EP (2) | EP2586778A3 (enExample) |
| JP (3) | JP5147866B2 (enExample) |
| KR (1) | KR20100049500A (enExample) |
| CN (1) | CN101730692A (enExample) |
| AR (1) | AR065721A1 (enExample) |
| AU (1) | AU2008227100B2 (enExample) |
| BR (1) | BRPI0809238A2 (enExample) |
| CA (1) | CA2680583A1 (enExample) |
| CL (1) | CL2008000725A1 (enExample) |
| CO (1) | CO6220966A2 (enExample) |
| EC (1) | ECSP099634A (enExample) |
| IL (1) | IL200906A0 (enExample) |
| MX (1) | MX2009009948A (enExample) |
| PE (1) | PE20081882A1 (enExample) |
| RU (1) | RU2009137946A (enExample) |
| TW (1) | TW200902516A (enExample) |
| WO (1) | WO2008115381A1 (enExample) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2137162T3 (en) | 2007-03-15 | 2018-11-26 | Novartis Ag | Organic compounds and their applications |
| EP2136808A2 (en) * | 2007-03-15 | 2009-12-30 | Schering Corporation | Piperazine-substituted pyridazinone derivatives useful as glucan synthase inhibitors |
| MX2010003117A (es) * | 2007-09-20 | 2010-04-01 | Irm Llc | Compuestos y composiciones como moduladores de la actividad de gpr119. |
| EP2296653B1 (en) | 2008-06-03 | 2016-01-27 | Intermune, Inc. | Compounds and methods for treating inflammatory and fibrotic disorders |
| US20100041663A1 (en) | 2008-07-18 | 2010-02-18 | Novartis Ag | Organic Compounds as Smo Inhibitors |
| AU2011313906B2 (en) * | 2010-10-11 | 2015-08-13 | Axikin Pharmaceuticals, Inc. | Salts of arylsulfonamide CCR3 antagonists |
| FI20115234A0 (fi) | 2011-03-08 | 2011-03-08 | Biotie Therapies Corp | Uusia pyridatsinoni- ja pyridoniyhdisteitä |
| GB201111704D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Novel compounds |
| GB201111705D0 (en) | 2011-07-07 | 2011-08-24 | Takeda Pharmaceutical | Compounds and their use |
| JO3115B1 (ar) * | 2011-08-22 | 2017-09-20 | Takeda Pharmaceuticals Co | مركبات بيريدازينون واستخدامها كمثبطات daao |
| AP2014007637A0 (en) | 2011-11-15 | 2014-05-31 | Takeda Pharmaceutical | Dihydroxy aromatic heterocyclic compound |
| EP2836482B1 (en) * | 2012-04-10 | 2019-12-25 | The Regents of The University of California | Compositions and methods for treating cancer |
| AU2013203000B9 (en) | 2012-08-10 | 2017-02-02 | Lantheus Medical Imaging, Inc. | Compositions, methods, and systems for the synthesis and use of imaging agents |
| CN103664795B (zh) * | 2012-09-06 | 2017-10-03 | 华东理工大学 | 哒嗪酮类化合物及其用途 |
| AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
| WO2014053973A2 (en) | 2012-10-05 | 2014-04-10 | Koninklijke Philips N.V. | Medical imaging system and method for providing an enhanced x-ray image |
| GB201222711D0 (en) | 2012-12-17 | 2013-01-30 | Takeda Pharmaceutical | Novel compounds |
| US11039617B2 (en) | 2013-01-30 | 2021-06-22 | Agrofresh Inc. | Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness |
| US10070649B2 (en) | 2013-01-30 | 2018-09-11 | Agrofresh Inc. | Volatile applications against pathogens |
| WO2015031036A1 (en) * | 2013-08-26 | 2015-03-05 | Purdue Pharma L.P. | Azaspiro[4.5] decane derivatives and use thereof |
| RU2692485C2 (ru) | 2014-04-02 | 2019-06-25 | Интермьюн, Инк. | Противофиброзные пиридиноны |
| CN106456708A (zh) * | 2014-04-24 | 2017-02-22 | 赫希玛有限公司 | 治疗的试剂和方法 |
| EP3426029B1 (en) | 2016-03-07 | 2023-08-30 | AgroFresh Inc. | Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops |
| RU2019132396A (ru) * | 2017-03-15 | 2021-04-15 | Лунелла Байотек, Инк. | Миторибосцины: терапевтические средства на основе митохондрий, направленные на раковые клетки, бактерии и патогенные дрожжи |
| BR112019020693B1 (pt) | 2017-04-03 | 2023-11-28 | Syngenta Participations Ag | Compostos derivados de oxadiazol microbiocidas, suas composições, método para controlar ou prevenir a infestação de plantas úteis por microrganismos fitopatogênicos utilizando tais compostos e seus usos |
| EP3684364A4 (en) | 2017-09-18 | 2021-06-02 | Goldfinch Bio, Inc. | PYRIDAZINONE AND METHOD OF USE THEREOF |
| CN109912476A (zh) * | 2019-03-27 | 2019-06-21 | 南通宝凯化工有限公司 | 一种异丙氨基磺酰氯的生产工艺 |
| WO2020253862A1 (zh) * | 2019-06-21 | 2020-12-24 | 上海翰森生物医药科技有限公司 | 含氮芳基磷氧化物类衍生物、其制备方法和应用 |
| WO2021113625A1 (en) * | 2019-12-06 | 2021-06-10 | Plexxikon Inc. | Compounds and methods for cd73 modulation and indications therefor |
| WO2021222353A1 (en) | 2020-04-30 | 2021-11-04 | Gilead Sciences, Inc. | Macrocyclic inhibitors of peptidylarginine deiminases |
| WO2023204124A1 (ja) * | 2022-04-20 | 2023-10-26 | 日本曹達株式会社 | ピリダジノン化合物並びに農園芸用殺菌剤、殺線虫剤、および医療用・動物用抗真菌剤 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS565734B2 (enExample) * | 1973-02-28 | 1981-02-06 | ||
| DE3048487A1 (de) * | 1980-12-22 | 1982-07-29 | Cassella Ag, 6000 Frankfurt | Basisch substituierte pyridazine, ihre herstellung und ihre verwendung |
| ES540813A0 (es) | 1985-02-28 | 1985-11-16 | Abello Quimicos Farma Prod Sa | Procedimiento de obtencion de 1,2-diazin-3 (2h)-onas con interes farmaceutico |
| JPH04235975A (ja) * | 1991-01-21 | 1992-08-25 | Nissan Chem Ind Ltd | ピリダジノン誘導体および害虫防除剤 |
| GB2256587A (en) | 1991-06-11 | 1992-12-16 | American Cyanamid Co | Acetazolamide in sustained release form |
| HU227237B1 (en) * | 2001-09-27 | 2010-12-28 | Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag | Substituted alkylpyridazinone derivatives, process for their preparation, pharmaceutical compositions containing them |
| CN1633434A (zh) * | 2002-01-31 | 2005-06-29 | 第一制药株式会社 | 咪唑并[1,2－a]吡啶衍生物 |
| DE10216144A1 (de) * | 2002-04-12 | 2003-11-06 | Bayer Ag | Substituierte 2-Phenyl-3(2H)-Pyridazinone |
| US20050209278A1 (en) * | 2002-04-25 | 2005-09-22 | Mcdonald Joseph J | Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| UA77526C2 (en) * | 2002-06-07 | 2006-12-15 | Sanofi Aventis | Substituted derivatives of 1-piperazineacylpiperidine, a method for the preparation thereof and their use in therapy |
| JP4768628B2 (ja) * | 2003-11-19 | 2011-09-07 | アレイ バイオファーマ、インコーポレイテッド | Ｍｅｋの二環系阻害剤及びその使用方法 |
| AU2005249380C1 (en) * | 2004-04-23 | 2012-09-20 | Exelixis, Inc. | Kinase modulators and methods of use |
| GB0524991D0 (en) * | 2005-12-08 | 2006-01-18 | Ge Healthcare Ltd | Novel imaging agents for fibrosis |
| WO2007130383A2 (en) * | 2006-04-28 | 2007-11-15 | Northwestern University | Compositions and treatments using pyridazine compounds and secretases |
| EP2136808A2 (en) * | 2007-03-15 | 2009-12-30 | Schering Corporation | Piperazine-substituted pyridazinone derivatives useful as glucan synthase inhibitors |
-
2008
- 2008-03-12 EP EP12196756.6A patent/EP2586778A3/en not_active Withdrawn
- 2008-03-12 KR KR1020097021457A patent/KR20100049500A/ko not_active Withdrawn
- 2008-03-12 AU AU2008227100A patent/AU2008227100B2/en not_active Ceased
- 2008-03-12 PE PE2008000469A patent/PE20081882A1/es not_active Application Discontinuation
- 2008-03-12 CN CN200880016155A patent/CN101730692A/zh active Pending
- 2008-03-12 EP EP08726734.0A patent/EP2137179B1/en active Active
- 2008-03-12 MX MX2009009948A patent/MX2009009948A/es not_active Application Discontinuation
- 2008-03-12 BR BRPI0809238-9A patent/BRPI0809238A2/pt not_active IP Right Cessation
- 2008-03-12 RU RU2009137946/04A patent/RU2009137946A/ru not_active Application Discontinuation
- 2008-03-12 CA CA002680583A patent/CA2680583A1/en not_active Abandoned
- 2008-03-12 US US12/046,755 patent/US8232274B2/en active Active
- 2008-03-12 JP JP2009553612A patent/JP5147866B2/ja not_active Expired - Fee Related
- 2008-03-12 WO PCT/US2008/003257 patent/WO2008115381A1/en not_active Ceased
- 2008-03-12 CL CL2008000725A patent/CL2008000725A1/es unknown
- 2008-03-13 TW TW097108919A patent/TW200902516A/zh unknown
- 2008-03-13 AR ARP080101033A patent/AR065721A1/es not_active Application Discontinuation
-
2009
- 2009-09-13 IL IL200906A patent/IL200906A0/en unknown
- 2009-09-14 CO CO09098894A patent/CO6220966A2/es not_active Application Discontinuation
- 2009-09-14 EC EC2009009634A patent/ECSP099634A/es unknown
-
2012
- 2012-10-18 JP JP2012230565A patent/JP2013014622A/ja active Pending
-
2013
- 2013-12-16 JP JP2013259117A patent/JP2014051529A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013014622A5 (enExample) | ||
| JP2014507446A5 (enExample) | ||
| JP2012107057A5 (enExample) | ||
| JP2012126725A5 (enExample) | ||
| JP2017509667A5 (enExample) | ||
| JP2014221779A5 (enExample) | ||
| JP2011105738A5 (enExample) | ||
| EP2833721A4 (en) | NICKEL OXIDE RELEASING PHARMACEUTICAL COMPOSITIONS | |
| HRP20250119T1 (hr) | Kdm1a inhibitor i njegova primjena u terapiji | |
| JP2013525444A5 (enExample) | ||
| JP2012143233A5 (enExample) | ||
| JP2015501783A5 (enExample) | ||
| ZA201501977B (en) | Orally administered medical composition | |
| JP2015525757A5 (enExample) | ||
| JP2011006431A5 (enExample) | ||
| JP2012255026A5 (enExample) | ||
| JP2013520167A5 (enExample) | ||
| JP2014530840A5 (enExample) | ||
| JP2019516735A5 (enExample) | ||
| JP2016535100A5 (enExample) | ||
| JP2016500312A5 (enExample) | ||
| JP2013532687A5 (enExample) | ||
| BR112014020992A2 (pt) | Composto,uso de composto na fabricação de um medicamento e composição farmacêutica | |
| GB201511770D0 (en) | Novel pharmaceutical formulationsand their use in the treatment of periodontal disease | |
| JP2011519871A5 (enExample) |